Barzuxetan

DB21132ExperimentalSmall molecule

Barzuxetan is a small molecule drug. The usage of the INN stem '-xetan' in the name indicates that Barzuxetan is a chelating agent. Barzuxetan has a monoisotopic molecular weight of...

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Formula / weight: C₂₆H₃₄N₄O₁₀S · 594.64 g/mol (avg)

Resolves to

Compound

UNIIR6D8CX2KCPCAS157380-45-5

Structure

InChIKeyQZVREUUCWLULJM-HKBOAZHASA-NSMILESOC(=O)CN(CC(O)=O)[C@@H](CN(CC(O)=O)[C@H]1CCCC[C@@H]1N(CC(O)=O)CC(O)=O)CC1=CC=C(C=C1)N=C=S

Targets

P00533EGFR

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Barzuxetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account